Association of Common Variants in TNFRSF13B, TNFSF13, and ANXA3 with Serum Levels of Non-Albumin Protein and Immunoglobulin Isotypes in Japanese by Osman, Wael et al.
Association of Common Variants in TNFRSF13B,
TNFSF13, and ANXA3 with Serum Levels of Non-Albumin
Protein and Immunoglobulin Isotypes in Japanese
Wael Osman
1, Yukinori Okada
2,3, Yoichiro Kamatani
4, Michiaki Kubo
5, Koichi Matsuda
1,
Yusuke Nakamura
1*
1Laboratory of Molecular Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2Laboratory for Statistical Analysis, Center for Genomic Medicine,
Institute of Physical and Chemical Research (Center for Genomic Medicine, RIKEN), Kanagawa, Japan, 3Department of Allergy and Rheumatology, Graduate School of
Medicine, The University of Tokyo, Tokyo, Japan, 4Centre d’Etude du Polymorphisme Humain, Paris, France, 5Laboratory for Genotyping Development, Center for
Genomic Medicine, RIKEN, Kanagawa, Japan
Abstract
We performed a genome-wide association study (GWAS) on levels of serum total protein (TP), albumin (ALB), and non-
albumin protein (NAP). We analyzed SNPs on autosomal chromosomes using data from 9,103 Japanese individuals, followed
by a replication study of 1,600 additional individuals. We confirmed the previously- reported association of GCKR on
chromosome 2p23.3 with serum ALB (rs1260326, Pmeta=3.1610
29), and additionally identified the significant genome-wide
association of rs4985726 in TNFRSF13B on 17p11.2 with both TP and NAP (Pmeta=1.2610
214 and 7.1610
224, respectively).
For NAP, rs3803800 and rs11552708 in TNFSF13 on 17p13.1 (Pmeta=7.2610
215 and 7.5610
210, respectively) as well as
rs10007186 on 4q21.2 near ANXA3 (Pmeta=1.3610
29) also indicated significant associations. Interestingly, TNFRSF13B and
TNFSF13 encode a tumor necrosis factor (TNF) receptor and its ligand, which together constitute an important receptor-
ligand axis for B-cell homeostasis and immunoglobulin production. Furthermore, three SNPs, rs4985726, rs3803800, and
rs11552708 in TNFRSF13B and TNFSF13, were indicated to be associated with serum levels of IgG (P,2.3610
23) and IgM
(P,0.018), while rs3803800 and rs11552708 were associated with IgA (P,0.013). Rs10007186 in 4q21.2 was associated with
serum levels of IgA (P=0.036), IgM (P=0.019), and IgE (P=4.9610
24). Our results should add interesting knowledge about
the regulation of major serum components.
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Introduction
Serum proteins possess various biological functions such as
hormones, enzymes, antibodies, and clotting agents, and some
serve as valuable biomarkers that reflect several disease
conditions. Major components of serum proteins are ALB
(approximately 60%), globulins (mainly as c-globulins, approxi-
mately 30%), and fibrinogens. Total serum protein levels range
from 6.5 to 8.5 g/dl and show significant inter-individual
variation. These variations are found to be influenced by
environmental factors. However, genetic factors are also known
to affect their levels although the range of genetic effects varies
by the reports from 20% to 77% [1]. Genome-wide association
studies (GWAS) recently demonstrated that serum levels of
several proteins can be strongly influenced by common genetic
variants through either cis or trans effects [2–4].
We previously reported the GWAS results for hematological
and biochemical traits, including TP and ALB, in the Japanese
population [5]. An associated SNP for TP, rs4273077 (P-
value=4.5610
210), is located in an intron of TNFRSF13B
(Tumor Necrosis Factor Receptor Superfamily member 13B),
which encodes TACI (transmembrane activator and calcium-
modulator and cytophilin interactor), one of three TNF-receptor
family members (BAFF-R, TACI, and BCMA) [6]. However,
since rs4273077 showed no significant association with the serum
ALB level (P=0.089), we suspected that this SNP would have
genetic effects primarily on the levels of the non-albumin
fraction. TACI is expressed mainly in activated B cells and
binds with a high affinity to two TNF ligands; APRIL (a
Proliferation-Inducing Ligand, encoded by TNFSF13), and BAFF
(B Cell-Activating Factor, encoded by TNFSF13B) [7]. TACI is
implicated in B- cell homeostasis (including B- cell survival,
activation, and differentiation), immunoglobulin production, and
antibody class switching [8–10]. Hence, the association of
variants in TNFRSF13B with TP is likely to reflect the
immunoglobulin serum levels.
The aim of this study is to identify the genetic variations
associated with serum levels of non-albumin proteins (NAP),
particularly those of immunoglobulins by GWAS of Japanese
subjects.
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GWAS of Total Protein (TP), Albumin (ALB), and Non-
albumin Protein (NAP)
We conducted a GWAS using genotyping data and clinical
information on 9,103 individuals who had been collected in the
BioBank Japan Project [11] (Table 1, Table S1). Genotyping was
performed using Illumina Human610-Quad BeadChip (Illumina,
CA, USA). After applying stringent quality control (QC) filters for
selection of individuals and SNPs (Materials and Methods), we
additionally performed whole-genome imputation analysis using
the data of HapMap Phase II East Asian populations, and we
obtained the information of 2,178,644 SNPs on autosomal
chromosomes with minor allele frequencies (MAF) of $0.01 and
Rsq of $0.7. We then evaluated the association of the SNPs with
the adjusted Z scores of serum levels of total protein (TP), albumin
(ALB), and non-albumin protein (NAP). A Quantile-quantile (Q-
Q) plot for each trait indicated low possibility of population
stratification (inflation factors (lGC) for TP, ALB and NAP were
1.04, 1.02 and 1.02, respectively) (Figure S2).
Several SNPs with strong linkage disequilibrium (LD) (r
2.0.8)
in intronic regions of TNFRSF13B on chromosome 17p11.2
showed significant associations with both TP and NAP
(rs4985726, P=2.8610
212 and 2.4610
222, respectively)
(Table 2, Table S2, Figure 1A and 1B, and Figure 2A and 2B).
In addition, rs3803800 and rs11552708 in coding regions of
TNFSF13 on chromosome 17p13.1 demonstrated significant
associations with NAP (P=1.8610
212 and 7.0610
29, respectively)
(Table 2, Figure 1B, and Figure 2C).
Since TNFSF13 encodes APRIL, a ligand of TACI encoded by
TNFRSF13B, this ligand- receptor interaction is likely to play a
critical role in regulation of the serum NAP levels. However, we
did not find any synergistic effects between SNPs in the receptor
and ligand on NAP levels.
Rs10007186 located near ANXA3 (annexin A3) on chromosome
4q21.2 also revealed significant association with NAP
(P=3.3610
29; Table 2, Figure 1B, and Figure 2D), and a cluster
of highly linked SNPs near the 59 flanking region of AFF3 (AF4/
FMR2 family, member 3) on 2q11.2 indicated suggestive
associations with NAP (rs4851274, P=9.95610
28) (Table S2).
For serum ALB, SNPs rs1260326 (in exon) and rs3817588 (in
intron) in GCKR (glucokinase regulator) on 2p23.3 revealed
significant associations (P=3.4610
28 and 4.1610
28, respectively)
(Figure 2E, Table 2, and Table S2).
Conditional logistic regression analysis for the SNPs on 17p13.1
indicated that both rs3803800 and rs11552708 conferred
independent associations with NAP levels when adjusted for each
other (P,0.023). These two SNPs were in strong LD (D9=0.99,
r
2=0.30) and the haplotype analysis of these two SNPs identified
that a haplotype (rs3803800 [A] – rs11552708 [G]) revealed
stronger association with NAP than individual SNP
(P=2.59610
213) (Table S3). Similarly, rs1260326 and
rs3817588 in GCKR exhibited independent associations with
ALB levels (P,0.022), and were in LD (D9=0.95, r
2=0.50).
Moreover, the haplotype (rs1260326 [C]–rs3817588 [C]) indicat-
ed stronger association with serum ALB (P=2.83610
29) (Table
S4). For the 17p11.2 and 4q21.2 loci, no SNP remained significant
after accounting for the effect of marker the SNPs rs4985726, and
rs10007186, respectively.
When we examined the genetic contribution of these variations
for the traits, the combinations of the SNPs indicated above could
explain nearly 0.5%, 2.3%, and 0.3% of variations in serum TP,
NAP, and ALB, respectively.
Replication Study
To validate the GWAS results, we performed a replication study
using an independent set of ,1,600 subjects from BioBank Japan
[11] (Table 1). For each trait, we selected marker SNPs for the
replication analysis at each locus that indicated the genome-wide
significant level of 5.0610
28 (rs4985726 in TNFRSF13B,
rs3803800 in TNFSF13, rs1260326 in GCKR, and rs10007186
on 4q21.2). In addition, the two SNPs that remained significant
after accounting for the effect of each marker SNP at two loci
(rs11552708 in TNFSF13 and rs3817588 in GCKR) were also
further investigated.
SNPs rs4985726 in the TNFRSF13B locus as well as rs3803800
and rs11552708 in the TNFSF13 locus revealed significant
associations with both TP and NAP (Table 2). The association
of rs1260326 in GCKR with serum ALB was also replicated
(P=0.029; Table 2). Meta-analyses combining the GWAS and the
replication study yielded stronger associations of these SNPs than
the GWAS alone (Table 2 and Figure 2A, B, C, and E).
Table 1. Characteristics of the examined proteins.
TP ALB NAP IgG
* IgA
* IgM
* IgE
*
GWAS Replication GWAS Replication GWAS Replication
No. 9,090 1,626 9,103 1,607 9,077 1,629 1,794 1,675 1,649 549
M6S.D
a 7.106
0.50
7.066
0.73
4.256
0.35
4.006
0.51
2.856
0.42
3.076
0.57
1.446
0.61
0.276
0.15
0.116
0.07
1306.546
5598.06
Age
b 69.526
10.44
59.526
15.43
69.526
10.44
59.546
15.39
69.516
10.44
59.486
15.52
59.706
15.46
59.386
15.73
59.426
15.57
62.546
18.61
Female % 37.45 45.08 37.41 45.12 37.46 45.12 55.30 54.57 54.88 63.93
BMI
b 22.916
3.45
23.316
5.67
22.916
3.45
23.346
5.69
22.916
3.45
23.296
5.67
23.176
5.00
23.206
5.09
23.196
5.07
22.736
4.22
Smokers % 42.11 51.91 42.11 52.15 42.05 51.81 51.90 51.82 52.27 48.63
Drinkers % 29.37 51.97 29.37 52.08 29.40 51.81 51.00 50.81 50.82 41.35
aM6S.D: mean value6standard deviation of each protein is indicated in g/dl except for IgE, which is indicated as IU/ml.
bAge and body mass index (BMI) are indicated as mean values6standard deviation.
*Log-transformed values were applied in the analysis.
Abbreviations: GWAS: genome-wide association study, TP: total protein, ALB: albumin, NAP: non-albumin protein.
doi:10.1371/journal.pone.0032683.t001
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replication study (P=0.065), and meta-analyses indicated that the
association was unlikely to be false positive (P=1.3610
29) (Table 2
and Figure 2D).
Association of the SNPs Identified in the GWAS of NAP
with Serum Immunoglobulin Isotypes
Immunoglobulin isotypes constitute the major components of
NAP. Hence, we further examined the NAP-associated SNPs in
the GWAS (TNFRSF13B, TNFSF13, and ANXA3) for the
association with various serum immunoglobulins using the samples
in BioBank Japan [11] (IgG: n=1,794, IgA: n=1,675, IgM:
n=1,649, and IgE: n=549; Table 1).
We found significant associations of rs4985726 in TNFRSF13B
as well as rs3803800 and rs11552708 in TNFSF13 with serum
levels of IgG (P,0.0023) and IgM(P,0.018) (Table 3). For IgA,
rs3803800 and rs11552708 in TNFSF13 also revealed the
significant association (P,0.013), while rs4985726 in TNFRSF13B
revealed no significant association (P=0.099) (Table 3).
Rs10007186 near ANXA3 indicated significant association with
IgA (P=0.036), IgM (P=0.019), and IgE (P=4.9610
24).
However, these associated SNPs explained only 1.4%, 0.9%,
1.3%, and 2.0% of the variances of log-transformed values of
serum IgG, IgA, IgM, and IgE, respectively.
Discussion
On the basis of the information of 10,716 Japanese individuals,
we identified one genetic locus (TNFRSF13B) on chromosome
17p11.2 associated with both TP and NAP, two loci (TNFSF13 on
17p13.1 and a region near ANXA3 on 4q21.2) associated with
NAP, and one locus (GCKR) on 2p23.3 associated with ALB at the
level of genome-wide significance.
The marker SNP rs4985726 shows association with TP and
NAP is located in an intron of TNFRSF13B on chromosome
17p11.2. A possible mechanism for its association with these traits
could be explained by its strong LD with rs34562254 (D9=1,
r
2=0.97), which exhibits a missense variation (C.T, Pro251Leu)
located in the intracellular domain of the receptor molecule. The
in silico prediction of the amino acid substitution by rs34562254 in
the PolyPhen-2 and SNPinfo database [12,13] suggested a
‘‘probably damaging’’ effect on the protein structure.
The SNPs in TNFSF13 (encoding APRIL) that identified as
being associated with NAP are missense variants; rs3803800
(A.G, Asn96Ser), and rs11552708 (G.A, Gly67Arg). APRIL was
first described as having a promoter function for tumor-cell
proliferation and survival [14]. APRIL is cleaved in the Golgi
apparatus by furin at its 104Arg/105Ala site [15], and
interestingly, rs3803800 is closely located to this cleavage site.
Hence, this SNP might affect the cleavage affinity. Another
possibility is the effect on splicing, because both SNPs are
predicted to be located within binding sites of splicing regulatory
elements [13]. However, further investigation should be required
to address these possibilities.
The SNP rs4985726 in TNFRSF13B as well as rs3803800 and
rs11552708, in TNFSF13 also revealed significant associations with
serum levels of IgG, IgA, and IgM. It is notable that the two genes
encode a TNF-receptor and ligand axis that plays important roles
for mediating antibody class switching and regulating immuno-
globulin production [8,9]. Furthermore, knockout mice of either
TNFRSF13B or TNFSF13 presented a common phenotype of the
IgA deficiency with impaired antibody response to T cell-
independent antigens [16]. In addition, germ-line mutations in
TNFRSF13B were reported in cases of common variable
immunodeficiency (CVID; MIM # 607594) and selective IgA
deficiency (IGAD; MIM # 137100) [17]. The combination of
these significant statistical and biological evidences would suggest
that the association of these two loci with NAP reflect at least their
associations with regulation of serum immunoglobulin levels. It is
also known that immunoglobulins are the major components of
NAP, which provides compelling evidence for our results. The
facts that both SNPs rs3803800 [A] and rs11552708 [G] in
TNFSF13 were reported to be associated with the susceptibility to
the Systemic Lupus Erythematosus (SLE) in the Japanese
population and that high serum APRIL was detected in the sera
of individuals with the rs3803800 [A]–rs11552708 [G] haplotype
[18] further support the significance of these SNPs in the
regulation of immunoglobulin production. In this study, we
observed that possession of two copies of SLE-risk alleles was
associated with higher serum levels of NAP, IgG, IgA, and IgM
(Figure S3), providing a good example of genetic loci that influence
both quantitative traits and susceptibility to complex diseases.
Rs10007186, which was associated with NAP
(Pmeta=1.3610
29) is located about 57.4 kb downstream of ANXA3
encoding annexin A3, a member of annexin family of calcium-
Table 2. Summary results of the GWAS and the replication study of TP, ALB, and NAP.
Trait SNP Chr: Position
Nearest
Gene
A1/
A2
a MAF GWAS Replication Meta analysis
%
variance
explained
Effect
b (s.e) P
c Effect
b (s.e) P
c Effect
b (s.e) P
c
TP rs4985726* 17:16804363 TNFRSF13B C/G 0.375 0.108 (0.015) 2.8610
212 0.100 (0.030) 0.0010 0.107 (0.0138) 1.2610
214 0.53
ALB rs1260326 2:27584444 GCKR T/C 0.445 20.082 (0.015) 3.4610
28 20.070 (0.032) 0.029 20.080 (0.014) 3.1610
29 0.32
NAP rs4985726* 17:16804363 TNFRSF13B C/G 0.375 0.148 (0.015) 2.4610
222 0.090 (0.028) 0.0013 0.135 (0.013) 7.1610
224 1.03
rs3803800 17:7403693 TNFSF13 G/A 0.311 0.108 (0.015) 1.8610
212 0.090 (0.029) 0.0022 0.104 (0.013) 7.2610
215 0.53
rs11552708 17:7403279 TNFSF13 G/A 0.401 20.084 (0.015) 7.0610
29 20.070 (0.027) 0.0091 20.081 (0.013) 7.5610
210 0.36
rs10007186* 4:79808069 ANXA3 T/C 0.307 0.095 (0.016) 3.3610
29 0.053 (0.029) 0.065 0.085 (0.014) 1.3610
29 0.38
aA1/A2: major/minor alleles.
bThe effect of the minor allele on the normalized values based on an additive genetic model.
cFor the GWAS and replication analysis, P-values were obtained by linear regression test model, for the Meta analysis by inverse-variance method.
*SNPs obtained by whole-genome imputation analysis.
Abbreviations: GWAS: genome-wide association study, MAF: minor allele frequency, TP: total protein, ALB: albumin, NAP: non-albumin protein, s.e: standard error.
doi:10.1371/journal.pone.0032683.t002
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found to be translocated into phagosomes in dendritic cells [20],
which are antigen-presenting cells that serve as messengers
between the innate and adaptive immune response, and play a
key role in allergic, inflammatory, and autoimmune conditions. In
addition, annexin A3 was also found to be associated with
neutrophil granule membranes [21], where it can play a regulatory
role in calcium-dependent granule secretions that contribute to
acute inflammation and chronic tissue destruction. The association
of rs10007186 with IgA, IgM, and IgE, would suggest additional
biological roles of annexin A3 in the immune response.
We also confirmed the association of SNPs in GCKR with serum
ALB levels (rs1260326, Pmeta=3.1610
29). Rs1260326 is a
missense variant (T.C, Leu446Pro) and predicted to cause a
damaging effect on the protein structure. GCKR is a locus
frequently associated with several metabolic traits [4,22–24] and
rs1260326 has been reported to be associated with serum
triglycerides [4].
Figure 1. Manhattan plots for the GWAS of (A) TP, (B) NAP, and (C) ALB. SNPs were plotted based on their physical chromosomal positions
(horizontal axis) together with their –log10 (P-values) in the GWAS (vertical axis). The black horizontal line shows the genome-wide significance
threshold of P=5.0610
28. The SNPs for which P-values were smaller than 1.0610
215 are indicated at the upper limit of the plots.
doi:10.1371/journal.pone.0032683.g001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e32683As a conclusion, the present study identified genetic loci that
influence the inter-individual variation in serum levels of TP, ALB,
and NAP. The loci associated with NAP encompass genes
encoding a TNF-receptor and its ligand, which are implicated in
biological roles in the immune system, and their associations with
immunoglobulin isotypes were demonstrated here. Our results
should add novel insight toward understanding the genetic
background contributing to the regulation of the serum levels of
NAP and its major components.
Materials and Methods
Study Cohorts
For the GWAS, 9,103 subjects derived from 10 disease cohorts
(colorectal cancer, breast cancer, prostate cancer, lung cancer,
gastric cancer, diabetes mellitus, peripheral artery disease, atrial
fibrillation, ischemic stroke, and myocardial infarction) were
selected, and for the replication study, we used data from
.1600 independent individuals selected from the BioBank Japan
Project [11] (Table 1 and Table S1). For immunoglobulin isotypes
analyses, the data from ,1,600 additional individuals in BioBank
Figure 2. Regional plots for the associations of the SNPs in the GWAS stage of TP, ALB and NAP. SNPs plotted with their –log10 (P-values)
in the GWAS based on their physical chromosomal positions. Genotyped SNPs are indicated as circles, while imputed SNPs are indicated as triangles.
The color scheme indicated the linkage disequilibrium displayed as r
2 values between all SNPs and the top-ranked SNP in each plot. The tested trait,
chromosomal locus, and the top-ranked SNPs (in purple color) in the GWAS and combined analyses together with their P-values are shown in each
plot. The blue lines represent the recombination rates estimated based on HapMap Phase II database. The plots were drawn using Locus Zoom
software.
doi:10.1371/journal.pone.0032683.g002
Table 3. Association of the SNPs in the GWAS of the NAP with immunoglobulin isotypes.
SNP Gene IgG IgA IgM IgE
Effect
a (s.e) P
b %EV Effect
a (s.e) P
b %EV Effect
a (s.e) P
b %EV Effect
a (s.e) P
b %EV
rs4985726 TNFRSF13B 0.071 (0.022) 1.4610
23 0.51 0.049 (0.030) 0.099 – 20.090 (0.032)5.9610
23 0.40 0.039 (0.064) 0.54 –
rs3803800 TNFSF13 20.074 (0.024)2.2610
23 0.47 20.086 (0.031)6.2610
23 0.39 20.082 (0.034)0.018 0.29 20.117 (0.067)0.080 –
rs11552708 TNFSF13 0.067 (0.022) 2.3610
23 0.46 0.072 (0.029) 0.013 0.31 0.078 (0.032) 0.014 0.31 0.059 (0.060) 0.33 –
rs10007186 ANXA3 20.018 (0.022)0.42 – 20.063 (0.030)0.036 0.20 20.078 (0.033)0.019 0.27 0.200 (0.057) 4.9610
24 2.02
aThe effect of the minor alleles on the standardized values.
bP-values for the associations of SNPs with each normalized immunoglobulin isotype obtained by using a linear regression model.
Abbreviations: s.e: standard error, %EV: percentage of the explanatory variance.
doi:10.1371/journal.pone.0032683.t003
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samples is updated annually using a standard questionnaire in the
66 hospitals participating in the project. Written informed consent
was obtained from all subjects. The research project was approved
by the ethical committees in the Institute of Medical Science, the
University of Tokyo, and the Center of Genomic Medicine,
RIKEN, Yokohama, Japan.
Genotyping and Quality Control (Q.C) Filters
In the GWAS, SNPs were genotyped using the Illumina
HumanHap610-Quad BeadChip (Illumina, CA, USA). After the
exclusion of samples with call rates of ,0.98, we excluded closely
related individuals (in 1
st or 2
nd degree kinships) using identity-by-
descent (IBD) evaluated by PLINK version 1.0.6 [25]. We also
excluded individuals who were outliers in the cluster analysis using
the principle component analysis performed by EIGENSTRAT
3.0 along with HapMap Phase II populations (Figure S1). In
addition, SNPs with call rates of ,0.99, MAF of ,0.01 and Hardy
Weinberg equilibrium of P ,1.0610
27 were excluded.
Genotyping data of the SNPs selected for replication analyses
and for testing with immunoglobulin levels were generated using
multiplex PCR- based Invader Assay (Third Wave Technologies,
Madison, WI, USA) [26]. Genotypes were judged by visual
inspection, following the application of QC measures of
individuals’ call rates of .98% and SNPs call rates of .99% of
individuals. We could not obtain the genotype data of rs3817588
in GCKR using the Invader assay.
Whole-genome Imputation of Genotypes
We performed whole-genome imputation of the GWAS subjects
in a two-step procedure, as described elsewhere [27]. HapMap
phase II Japanese (JPT) and Han Chinese (CHB) individuals
(release 24) were adopted as reference panels. We excluded the
imputed SNPs with MAF of ,0.01 or Rsq of ,0.7. As a result, a
total of 2,178,644 SNPs on autosomal chromosomes were used for
the GWAS.
Statistical Analysis
We obtained the non-transformed values of TP, ALB and NAP
(mg/dl) for the subjects from the clinical information stored in
BioBank Japan [11], and adjusted them in linear regression
models with age, gender, body mass index (BMI), smoking,
drinking status, and affection status of the disease as covariates.
The residuals were then normalized as Z scores and subjects with
Z scores of ,24o r.4 were removed from each trait analysis.
The associations of the SNPs with Z scores were evaluated in
linear regression models assuming additive effects of allele dosages,
using mach2qtl software. The same methods of data normalization
and statistical models were applied for the replication analyses and
for testing the association with common log-transformed values of
immunoglobulin isotypes (IgG IgA, IgM, and IgE). Meta-analyses
of the GWAS and the replication study were performed using the
inverse-variance method assuming a fixed-effects model.
The significance level used was 5610
28 in the GWAS stage. For
the replication stage, we considered 0.05 as significant for the
association of rs4985726 with TP and rs1260326 with ALB. For
the association of SNPs rs4985726 in TNFRSF13B, rs3803800
and rs11552708 in TNFSF13 with NAP, 0.017 (0.05/3) was
considered to be significant. These significance levels represent the
Bonferroni correction for multiple statistical tests. In addition, we
set a level of 0.05 to consider the association of the selected SNPs
with immunoglobulin isotypes as significant.
The haplotype analyses were performed using the Haplo Stats
package (version 1.4.0) implemented in R statistical software.
Epistatic effects of the SNPs in TNFRSF13B and TNFSF13 were
evaluated using a linear regression model incorporating the
product of the allele dosages of the SNPs in the loci as an
independent variable. All statistical analyses including haplotype
analyses were performed using the R statistical software version
2.9.1 except for genome-wide linear regression analyses. LD
analyses were performed using Haploview 4.2 software, PLINK,
and the SNAP database.
Web Resources
The URLs for the data presented in this paper are as follows:
The BioBank Japan Project, http://biobankjp.org/
PLIKN software, http://pngu.mgh.harvard.edu/ ˜purcell/plink/
EIGENSTRAT software, http://genepath.med.harvard.edu/
˜reich/EIGENSTRAT.htm
The International HapMap Project, http://www.hapmap.org/
MACH and mach2qtl software, http://www.sph.umich.edu/
csg/abecasis/MaCH/index.html
R statistical environment, http://www.r-project.org/
Haploview software, www.broad.mit.edu/mpg/haploview/
SNAP, http://www.broadinstitute.org/mpg/snap/ldsearch.
php
Locus Zoom, http://csg.sph.umich.edu/locuszoom/
Supporting Information
Figure S1 Principal component analysis Plot of cohorts
included in the GWAS. All individuals who were finally
incorporated in the GWAS together with the four populations in
the HapMap Phase II database (Japanese: JPT; Han Chinese:
CHB; Africans: YRI, and European: CEU) were plotted based on
the first two eigenvectors.
(PDF)
Figure S2 Quantile-Quantile (Q-Q) plots for the GWAS
of (A) TP, (B) NAP, and (C) ALB. The inflation factor, lGC, for
the analysis is shown in the legend of each plot. The SNPs for
which P-values were smaller than 1.0610
215 are indicated at the
upper limit of the plots.
(PDF)
Figure S3 Relationship between the genotypes of SNPs
identified in the study and the levels of tested proteins:
(A) rs4985726, (B) rs3803800, (C) rs11552708, (D)
rs10007186, and (E) rs1260326. For each box plot, the bold
line indicates the median value which is the 50
th quartile. The
limits of each box are the 25
th and 75
th quartiles.
(PDF)
Table S1 Characteristics of the GWAS cohorts.
(DOC)
Table S2 SNPs showed suggestive associations with
each examined trait (P,1.0610
26).
(DOC)
Table S3 Haplotype analysis of rs3803800 and
rs11552708 in TNFSF13 in association with NAP.
(DOC)
Table S4 Haplotype analysis of rs1260326 and
rs3817588 in GCKR in association with ALB.
(DOC)
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